• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TRIVIDIA HEALTH, INC. TRUEMETRIX; BLOOD GLUCOSE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TRIVIDIA HEALTH, INC. TRUEMETRIX; BLOOD GLUCOSE SYSTEM Back to Search Results
Model Number TRUEMETRIX
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 03/27/2017
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Product not yet returned for evaluation.Most likely underlying root cause of malfunction: user had an inaccurate reference.(b)(4).
 
Event or Problem Description
Consumer reported complaint for high blood glucose test results.The customer is concerned with tests results from results obtained of 227, 202, 235 and 296 mg/dl.The customer's expected fasting blood glucose test result range is 150 to 160mg/dl.The customer feels well and did not report any symptoms.Medical attention is not reported as a result of the actual blood glucose results.The product is stored according to specification.During the call on (b)(6) 2017, a back to back blood test was performed by the customer fasting and produced test results of 180 and 217mg/dl using true metrix meter.The test strip lot manufacturer's expiration date is 04/30/2018 and open vial date is (b)(6) 2017.The meter memory was reviewed for previous test result history (date / time not set): (b)(6).The customer is comparing his results to what he used to get on his true track meter.
 
Additional Manufacturer Narrative
(b)(4).Returned meter and returned test strips evaluated with no defects found.Most likely underlying root cause of malfunction: user had an inaccurate reference.Test strip udi# (b)(4).
 
Event or Problem Description
Consumer reported complaint for high blood glucose test results.The customer is concerned with tests results from results obtained of 227, 202, 235 and 296 mg/dl.The customer's expected fasting blood glucose test result range is 150 to 160 mg/dl.The customer feels well and did not report any symptoms.Medical attention is not reported as a result of the actual blood glucose results.The product is stored according to specification.During the call on (b)(6) 2017, a back to back blood test was performed by the customer fasting and produced test results of 180 and 217 mg/dl using true metrix meter.The test strip lot manufacturer's expiration date is 04/30/2018 and open vial date is (b)(6) 2017.The meter memory was reviewed for previous test result history (date / time not set): (b)(6).The customer is comparing his results to what he used to get on his true track meter.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRUEMETRIX
Common Device Name
BLOOD GLUCOSE SYSTEM
Manufacturer (Section D)
TRIVIDIA HEALTH, INC.
2400 nw 55th court
fort lauderdale FL 33309
MDR Report Key6509172
Report Number1000113657-2017-00706
Device Sequence Number19165218
Product Code NBW
UDI-Device Identifier00087701426520
UDI-Public(01)00087701426520
Combination Product (Y/N)N
Initial Reporter StateWA
PMA/510(K) Number
K140100
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source consumer
Initial Reporter Occupation Other
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 04/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model NumberTRUEMETRIX
Device Catalogue NumberRE4H01-81
Device Lot NumberMT2209
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/20/2017
Was the Report Sent to FDA? No
Event Location Home
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 03/27/2017
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date04/20/2017
Supplement Report FDA Received Date04/26/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SECOND THERAPY
-
-